NorthCrest Asset Manangement’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $426K | Hold |
3,277
| – | – | 0.01% | 447 |
|
|
2025
Q1 | $419K | Buy |
3,277
+1
| +0% | +$128 | 0.01% | 455 |
|
|
2024
Q4 | $433K | Sell |
3,276
-14
| -0.4% | -$1.85K | 0.01% | 421 |
|
|
2024
Q3 | $479K | Buy |
3,290
+360
| +12% | +$52.4K | 0.01% | 407 |
|
|
2024
Q2 | $402K | Sell |
2,930
-35
| -1% | -$4.8K | 0.01% | 413 |
|
|
2024
Q1 | $407K | Buy |
2,965
+65
| +2% | +$8.92K | 0.01% | 408 |
|
|
2023
Q4 | $394K | Sell |
2,900
-1,472
| -34% | -$200K | 0.01% | 412 |
|
|
2023
Q3 | $535K | Sell |
4,372
-60
| -1% | -$7.34K | 0.02% | 352 |
|
|
2023
Q2 | $563K | Sell |
4,432
-295
| -6% | -$37.5K | 0.02% | 340 |
|
|
2023
Q1 | $611K | Buy |
+4,727
| New | +$611K | 0.03% | 327 |
|
|
2022
Q3 | – | Sell |
-1,758
| Closed | -$207K | – | 435 |
|
|
2022
Q2 | $207K | Hold |
1,758
| – | – | 0.01% | 418 |
|
|
2022
Q1 | $229K | Sell |
1,758
-242
| -12% | -$31.5K | 0.01% | 381 |
|
|
2021
Q4 | $305K | Buy |
+2,000
| New | +$305K | 0.02% | 360 |
|